Table 2.
Baseline characteristics stratified by mortality and survival of patients with a certified outcome in Mashhad City from Feb 14, to May 11, 2020
| Reference | All patients | Non-survivors | Survivors | p-value |
|---|---|---|---|---|
| Number of patients (%) | 2943 (100) | 707 (24) | 2236 (76) | |
| Median age of the patients | 57.0 | 68.0 | 52.0 | 0.0001* |
| Age range | 40.0–71.0 | 59.0–79.0 | 36.0–66.0 | |
| Days from onset to hospital admission | 2.0 | 2.0 | 2.0 | 0.0695 |
| Range of days | 1.0–4.0 | 0.0–4.0 | 1.0–4.0 | |
| Days from hospital admission to outcome | 5.0 | 6.0 | 4.0 | < 0.0001* |
| Range of days | 2.0–8.0 | 2.0–10.0 | 2.0–7.0 | |
| Demographics & Clinical Characteristics | Number (%) | Number (%) | Number (%) | |
| Sex | … | … | … | 0.5832 |
| Female | 1179 (40.06) | 277 (39.18) | 902 (40.34) | … |
| Male | 1764 (59.94) | 430 (60.82) | 1334 (59.66) | … |
| Co-morbidity | ||||
| Diabetes | 405 (13.76) | 129 (18.25) | 276 (12.34) | 0.0001* |
| CVD | 614 (20.86) | 197 (27.86) | 417 (18.64) | < 0.0001* |
| Liver disorders | 89 (3.02) | 28 (3.96) | 61 (2.72) | 0.0953 |
| CRD | 120 (4.07) | 38 (5.37) | 82 (3.67) | 0.0453* |
| Nervous diseases | 69 (2.34) | 28 (3.96) | 41(1.83) | 0.0011* |
| COPD | 181 (6.15) | 71 (10.04) | 110 (4.91) | < 0.0001* |
| Malignancy (any) | 73 (2.48) | 39 (5.51) | 34 (1.52) | < 0.0001* |
| Initial symptoms | ||||
| Fever | 1720 (58.44) | 385 (54.45) | 1335 (59.70) | 0.0135* |
| Cough | 1874 (63.67) | 378 (53.46) | 1496 (66.90) | < 0.0001* |
| Dyspnoea | 2111 (71.72) | 579 (81.90) | 1532 (68.51) | < 0.0001* |
| Weakness | 533 (18.11) | 122 (17.25) | 411 (18.38) | 0.4984 |
| Myalgia | 429 (14.57) | 71 (10.04) | 358 (16.01) | < 0.0001* |
| Dizziness | 247 (8.39) | 80 (11.31) | 167 (7.47) | 0.0013* |
| Sore throat | 352 (11.96) | 47 (6.64) | 305 (13.64) | < 0.0001* |
| Sputum | 55 (1.86) | 5 (0.70) | 50 (2.23) | 0.0088* |
| Diarrhoea | 101 (3.43) | 16 (2.26) | 85 (3.80) | 0.0501 |
| Nausea or vomiting | 246 (8.36) | 39 (5.51) | 207 (9.26) | 0.0017* |
| Headache | 245 (8.32) | 35 (4.95) | 210 (9.39) | 0.0001* |
| Chest pain | 223 (7.57) | 49 (6.93) | 174 (7.78) | 0.2906 |
| Abdominal pain | 39 (1.32) | 3 (0.42) | 36 (1.61) | 0.0162* |
| Arthralgia | 176 (5.98) | 25 (3.53) | 151 (6.75) | 0.0016* |
| Pharyngitis | 37 (1.25) | 6 (0.85) | 31 (0.14) | 0.2633 |
| Conjunctivitis | 18 (0.61) | 2 (0.28) | 15 (0.72) | 0.1984 |
| Seizure | 22 (0.75) | 6 (0.85) | 16 (0.71) | 0.7203 |
| Abnormal chest X-ray | 697 (23.68) | 186 (26.30) | 511 (22.85) | 0.0596 |
| End-points | ||||
| ICU admission | 338 (11.48) | 150 (21.21) | 188 (8.40) | < 0.0001* |
| Ventilator | 549 (18.65) | 209 (29.56) | 340 (15.20) | < 0.0001* |
| Coma | 19 (0.65) | 9 (1.27) | 10 (0.45) | 0.0168* |
| Disease severity status | … | … | … | 0.0033* |
| General | 2418 (82.16) | 551 (77.93) | 1867 (83.50) | … |
| Severe | 503 (17.09) | 150 (21.22) | 353 (15.78) | … |
| Critical | 22 (0.75) | 6 (0.85) | 16 (0.72) | … |
CVD Cardiovascular Diseases, CRD Chronic Renal Diseases, COPD Chronic Obstructive Pulmonary Diseases, ICU Intensive Care Unit. *Significant values